Skip Navigation


Issue No. 31 | December 31, 2015
A Service of the U.S. Department of Health and Human ServicesView HTML version
News and Features 

FDA Updates Saquinavir Labeling

“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir."

“Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.”

The updated labeling will be available at the FDA website.

More information is available:

Recent HIV/AIDS News from FDA and NIAID

From FDA:


Home | Guidelines | Clinical Trials | Drugs | Health Topics | Education Materials | Mobile Resources & Tools
Contact Us
Left footer corner image Left footer corner image